Giant coronary aneurysms in an infant: Dilemma of MIS-C
Alexandra Drury1, Kelsey Wold2, Steven Healan3
1Washington State University/Elson S. Floyd College of Medicine, Spokane, Washington, USA.
Insights
Multisystem inflammatory syndrome in children (MIS-C) following COVID-19 can cause giant coronary artery aneurysms. Early detection and aggressive treatment are crucial for managing this pediatric condition.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Immunology
Background:
- COVID-19 can trigger multisystem inflammatory syndrome in children (MIS-C).
- Cardiovascular complications, including coronary artery abnormalities, are common in MIS-C.
- Most coronary artery issues in MIS-C are transient dilations or small aneurysms.
Observation:
- A 3-month-old infant developed giant coronary artery aneurysms (LAD and RCA) 26 days post-COVID-19 diagnosis.
- The infant received treatment with IVIG, infliximab, glucocorticoids, aspirin, clopidogrel, and enoxaparin.
- Despite treatment, persistent giant aneurysms with high z-scores (LAD ~35, RCA ~30) were noted.
Findings:
- The case highlights persistent giant coronary artery aneurysms in MIS-C, exceeding typical transient presentations.
- The patient showed no signs of coronary ischemia or cardiac dysfunction despite severe aneurysms.
- Aggressive medical management did not lead to resolution of the giant aneurysms in this case.
Implications:
- Emphasizes the need for vigilant monitoring of coronary arteries in children with MIS-C.
- Suggests that some MIS-C cases may develop severe, persistent coronary artery aneurysms requiring further investigation.
- Underscores the importance of early diagnosis and tailored, aggressive management strategies for pediatric cardiovascular complications of MIS-C.
Abstract:
COVID-19 related multisystem inflammatory syndrome in children (MIS-C) can present with cardiovascular complications like shock, arrhythmias, pericardial effusion, and coronary artery dilatation. The majority of MIS-C associated coronary artery abnormalities are dilation or small aneurysms which are transient and resolve in a few weeks. We present here a case of a 3-month-old child who was noted to have giant aneurysms of her coronary arteries (LAD and RCA) 26 days after testing positive for COVID-19. She was treated with IVIG, infliximab, and glucocorticoids along with aspirin, clopidogrel, and enoxaparin. She did not show any signs of coronary ischemia or cardiac dysfunction but continued to have persistent giant coronary artery aneurysms involving the LAD (z-score ∼35) and RCA (z-score ∼30). This study emphasizes the importance of early detection and aggressive management of MIS-C to prevent potentially life-threatening consequences.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...


